Could This Catalyst That Spark Rivian Stock Gains in 2024
Rivian has faced a steep stock decline since its 2021 IPO. This piece explores whether could this catalyst that sits ...
Why Is Dow Jones Price Weighted
This brief explainer covers why the Dow Jones uses price weighting, its impact on index movements, and practical considerations for investors evaluating the index.
25,255 articles
Energy ETFs Riding Oil’s Surge to Gains in 2026
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
AXT'S Sold Shares Worth: Should Investors Buy or Sell Now
Insider activity often sparks debate among investors. This article breaks down AXT's sold shares worth $1.41 million ...
Prem Watsa Adds Million: Is UA Turnaround Worth It Now?
When a veteran value investor piles into a beaten-down name, traders take notice. Prem Watsa recently added to his Un...
Dutch Bros Doubled Over: Can It Triple by 2030 and Beyond?
Dutch Bros has shown rapid growth in recent years. This investing guide breaks down how the company wins customers, w...
Holdings Sells Nearly Shares: Insider Moves Explained
Insider stock moves can signal many things. This guide unpacks a high-profile CEO sale, explains what to look for, an...
Where Will QuantumScape (QS) Stock Be in 3 Years Ahead?
QuantumScape's solid-state battery efforts could redefine EV charging. This guide digs into what might drive QS stock...
What Does Nayax President's Sale Mean for Investors?
A recent Insider Form 4 reveals Nayax Ltd.'s President sold 4,500 shares after exercising options. Here’s how to read...
AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Amgen: Biotech Giant's Path to Growth and Recovery
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
CareDx's Sells Shares: CEO Insider Move Shaping Stock
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...
Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status